 For instance, modafinil produces wakefulness reportedly without the need for compensatory sleep, and shows a relatively low, if any, potential for abuse.Aside from modafinil, examples of other atypical DAT inhibitors include vanoxerine and benztropine, which have a relatively low abuse potential similarly to modafinil.These drugs appear to interact molecularly with the DAT in a distinct way relative to "conventional" DAT blockers such as cocaine and methylphenidate.